Markus Joerger
- Oncology top 1%
- Cancer Treatment and Pharmacology 45
- Colorectal Cancer Treatments and Studies 39
- Cancer Immunotherapy and Biomarkers 31
- Lung Cancer Research Studies 19
- Pancreatic and Hepatic Oncology Research 14
- Neutropenia and Cancer Infections 14
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 17
-
- Lung Cancer Treatments and Mutations 43
- Pharmacology top 2%
- Co-authors
- Jan H.M. SchellensJos H. BeijnenAlwin D. R. HuitemaSilke GillessenNicole HagnerCarlo R. LargiadèrMartin FrühThomas Cerny
- Journals
- Journal of Clinical Oncology (27 papers)Annals of Oncology (20 papers)Cancer Chemotherapy and Pharmacology (12 papers)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Markus Joerger
206 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 132
- Oncology 2.2k
- Cancer Research 776
- Pulmonary and Respiratory Medicine 1.1k
- Pharmacology 248
- Pathology and Forensic Medicine 458
Countries citing papers authored by Markus Joerger
This map shows the geographic impact of Markus Joerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Joerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Joerger more than expected).
Fields of papers citing papers by Markus Joerger
This network shows the impact of papers produced by Markus Joerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Joerger. The network helps show where Markus Joerger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Joerger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 53 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 15 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2020 | 21 | |
| 17 | 2019 | 5 | |
| 18 | 2019 | 10 | |
| 19 | 2015 | 35 | |
| 20 | 2015 | 64 |
About Markus Joerger
Markus Joerger is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 215 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (45 papers), Lung Cancer Treatments and Mutations (43 papers), Colorectal Cancer Treatments and Studies (39 papers), Cancer Immunotherapy and Biomarkers (31 papers), Lung Cancer Research Studies (19 papers), Cancer Genomics and Diagnostics (17 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Neutropenia and Cancer Infections (14 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (776 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Markus Joerger has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Jan H.M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema, Silke Gillessen, Nicole Hagner, Carlo R. Largiadèr, Martin Früh, Thomas Cerny, Tanja K. Froehlich and Ursula Amstutz. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, Lung Cancer and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.